NPR logo Johnson & Johnson Expands Recall Of Drugs With Moldy Odor

Your Health

Johnson & Johnson Expands Recall Of Drugs With Moldy Odor

More on the Tylenol recall front: Johnson & Johnson and its subsidiary, McNeil Consumer Healthcare, are expanding a recall begun in January of a variety of over-the-counter medicines with a musty, moldy odor.

And once again, the odor is being blamed on the packaging and shipping materials - not the drugs themselves.

The odor has been linked to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole (TBA), according to the FDA's press release today

The company says the recall is precautionary and the odor is not likely to be dangerous. It announced the recall after an internal review showed that "some packaging materials used in the lots had been shipped and stored on the same type of wooden pallet that was tied to the presence of TBA in earlier recalled lots."

Since the initial January 15 recall, McNeil stopped accepting shipments of materials on that type of pallet.

The latest recall affects specific lots of Benadryl Allergy Ultratabs, Children's Tylenol Meltaway Strips in Bubblegum flavor, and Motrin IB sold in the United States, Fiji, Guatemala, Dominican Republic, Puerto Rico, Trinidad & Tobago, and Jamaica.

For a complete list of products, see here.

The company is asking customers who have these products to stop using them and contact the company for a refund or a replacement.

The string of recalls in the last year, including a highly publicized problem with kids' medicines and bad publicity from Congressional inquiries could cause the company's sales to plunge and consumers to lose confidence in a trusted household name.

"This is pain by a thousand cuts," analyst Steve Brozak of WBB Securites told the AP of the repeated recalls.